Hui Qu

1.7k total citations
36 papers, 1.3k citations indexed

About

Hui Qu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hui Qu has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Hui Qu's work include Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Hui Qu is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Hui Qu collaborates with scholars based in China, United States and Germany. Hui Qu's co-authors include Changgeng Qian, Xiong Cai, Rudi Bao, Cheng-Jung Lai, Ling Yin, Hai-Xiao Zhai, Jeffrey Forrester, Da-Gong Wang, Guang-Xin Xu and Ruzanna Atoyan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Hui Qu

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Qu China 16 908 412 300 166 162 36 1.3k
Linda Kessler United States 14 746 0.8× 352 0.9× 127 0.4× 137 0.8× 75 0.5× 38 1.1k
Richard Woessner United States 20 1.2k 1.3× 738 1.8× 185 0.6× 137 0.8× 103 0.6× 45 1.6k
Zilan Song China 18 597 0.7× 332 0.8× 343 1.1× 153 0.9× 41 0.3× 38 1.0k
Vanessa Baeriswyl Switzerland 12 728 0.8× 452 1.1× 150 0.5× 92 0.6× 190 1.2× 14 1.1k
Susan E. Morgan-Lappe United States 11 827 0.9× 406 1.0× 171 0.6× 40 0.2× 190 1.2× 20 1.1k
Suhu Liu United States 18 946 1.0× 476 1.2× 287 1.0× 44 0.3× 333 2.1× 34 1.4k
A. Coates United States 11 678 0.7× 802 1.9× 246 0.8× 75 0.5× 123 0.8× 19 1.3k
Thomas B. Sundberg United States 14 765 0.8× 297 0.7× 183 0.6× 110 0.7× 80 0.5× 17 1.0k
Da-Gong Wang United Kingdom 8 910 1.0× 440 1.1× 248 0.8× 89 0.5× 53 0.3× 11 1.1k
Mary J. C. Ludlam United States 6 673 0.7× 259 0.6× 222 0.7× 55 0.3× 66 0.4× 8 937

Countries citing papers authored by Hui Qu

Since Specialization
Citations

This map shows the geographic impact of Hui Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Qu more than expected).

Fields of papers citing papers by Hui Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Qu. The network helps show where Hui Qu may publish in the future.

Co-authorship network of co-authors of Hui Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Qu. A scholar is included among the top collaborators of Hui Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Qu. Hui Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cen, Xufeng, Si‐Jia Chen, Dong Liu, et al.. (2025). TJ0113-induced mitophagy in acute liver failure detected by Raman microspectroscopy. Redox Biology. 83. 103654–103654. 1 indexed citations
3.
Cen, Xufeng, Ting Ye, Hui Qu, et al.. (2025). TJ0113 attenuates fibrosis in metabolic dysfunction-associated steatohepatitis by inducing mitophagy. International Immunopharmacology. 156. 114678–114678. 2 indexed citations
4.
Zheng, Yuanwen, Jing Shen, Yong Chen, et al.. (2025). Chenodeoxycholic acid modulates cholestatic niche through FXR/Myc/P-selectin axis in liver endothelial cells. Nature Communications. 16(1). 2093–2093. 7 indexed citations
5.
Qu, Hui, et al.. (2025). The past, present, and future of ALK-targeted drug discovery. European Journal of Medicinal Chemistry. 299. 118053–118053.
6.
Qu, Hui, et al.. (2025). Design of a Highly Active Peptide Inhibitor of Farnesyltransferase and Its Protective Effect Against Acute Liver Failure. Drug Design Development and Therapy. Volume 19. 1909–1926. 1 indexed citations
7.
Tang, Xiaolong, et al.. (2024). Single-cell profiling reveals altered immune landscape and impaired NK cell function in gastric cancer liver metastasis. Oncogene. 43(35). 2635–2646. 13 indexed citations
8.
Tang, Xiaolong, Guorui Sun, Qingsi He, et al.. (2022). Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer. Cell Death and Disease. 13(10). 848–848. 28 indexed citations
9.
Zhu, Zheng, Guoyin Li, Zhenning Li, et al.. (2022). Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma. Frontiers in Immunology. 13. 914612–914612. 8 indexed citations
10.
Tang, Xiaolong, Guorui Sun, Qingsi He, et al.. (2020). Circular noncoding RNA circMBOAT2 is a novel tumor marker and regulates proliferation/migration by sponging miR-519d-3p in colorectal cancer. Cell Death and Disease. 11(8). 625–625. 29 indexed citations
11.
Wang, Weijia, et al.. (2020). Translation regulatory long non‑coding RNA 1 represents a potential prognostic biomarker for colorectal cancer. Oncology Letters. 19(6). 4077–4087. 8 indexed citations
12.
Zhou, Yuping, Hui Qu, Liyun Fu, et al.. (2018). Preliminary screening and functional analysis of circular RNAs associated with hepatic stellate cell activation. Gene. 677. 317–323. 31 indexed citations
13.
Chen, Cheng, et al.. (2018). Knockdown of RAI14 suppresses the progression of gastric cancer. OncoTargets and Therapy. Volume 11. 6693–6703. 20 indexed citations
14.
Zhang, Weiwei, et al.. (2016). The role of Golgi reassembly and stacking protein 65 phosphorylation in H2O2-induced cell death and Golgi morphological changes. Medical Molecular Morphology. 49(4). 217–223. 2 indexed citations
15.
16.
Zhang, Xue, et al.. (2015). CCR6 overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Clinical & Translational Oncology. 18(7). 700–707. 11 indexed citations
17.
Qian, Changgeng, Cheng-Jung Lai, Rudi Bao, et al.. (2012). Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling. Clinical Cancer Research. 18(15). 4104–4113. 188 indexed citations
18.
19.
Bao, Rudi, Cheng-Jung Lai, Hui Qu, et al.. (2009). CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy. Clinical Cancer Research. 15(12). 4046–4057. 80 indexed citations
20.
Bao, Rudi, Cheng-Jung Lai, Da-Gong Wang, et al.. (2009). Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer. Molecular Cancer Therapeutics. 8(12). 3296–3306. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Kessler Breakdown of academic impact, for papers by Richard Woessner Breakdown of academic impact, for papers by Zilan Song Breakdown of academic impact, for papers by Vanessa Baeriswyl Breakdown of academic impact, for papers by Susan E. Morgan-Lappe Breakdown of academic impact, for papers by Suhu Liu Breakdown of academic impact, for papers by A. Coates Breakdown of academic impact, for papers by Thomas B. Sundberg Breakdown of academic impact, for papers by Da-Gong Wang Breakdown of academic impact, for papers by Mary J. C. Ludlam
Rankless by CCL
2026